Drug Security Forum

Strategy for Introducing Personalized Medicine

14 Jun , 12:15–13:45
‘Ensuring Drug Security’ Russian Pharmaceutical Forum
Pavilion G, conference hall G5

The causes and mechanisms of a whole range of complex multifactorial diseases such as cancer, diabetes, Alzheimer’s disease, and autoimmune and metabolic conditions are now known. Reductionist medicine, focused on identifying the ‘main’ cause of disease and the areas for therapeutic action, is a thing of the past. The precise mechanisms of the orchestration of events leading to pathologies and endogenous factors contributing to the progression of a disease are already known. The depth of this knowledge opens the door to precision medicine, in which it is possible to select treatment strategies based on the specific current mechanisms of how an illness develops, what course it takes, and the precise molecular profile. Moreover, by taking into account the physiology, environment, lifestyle factors and history of each individual patient, personalized approaches tailored to each patient are possible as part of precision medicine. This paradigm necessitates a change in the principles of clinical research: conducting it in small groups of differentiated patients with particular characteristics. What actions and decisions are required of industry participants – regulators, developers, manufacturers, doctors, and patients – in the practice of precision medicine? Is the pharmaceutical industry prepared to differentiate its approaches to the development and introduction of different drug combinations and different approaches to a single disease? How will the transition to personalized medicine expand the market for medicines and revitalize approaches to treatment?

Alexey Martynov, President, Association of Biomedical Cellular Products Manufacturers

Alexey Belyaev, Director, National Medical Research Center of Oncology named after N.N. Petrov of the Ministry of Health of the Russian Federation
Danica Grujicic, Minister of Health of the Republic of Serbia
Andrey Kaprin, General Director, Federal State Budgetary Institution National Medical Research Radiological Centre of the Ministry of Health of the Russian Federation; Сhief Freelance Specialist Oncologist of the Ministry of Health of the Russian Federation (online)
Dmitry Kudlay, Vice President for the Implementation of New Medical Technologies, Generium
Maria Makarova, Doctor, Evogen, Russian Scientific Center for Radiology
Evgeny Shlyakhto, General Director, Almazov National Medical Research Centre of the Ministry of Health of the Russian Federation
Tatyana Yakovleva, First Deputy Head, Federal Medical-Biological Agency of the Russian Federation

Front row participants
Timur Akhmerov, General Director, BARS Group
Vladimir Ivanov, Chief Executive Officer, Medgital
Sergey Kutsev, Director of the Federal State Budgetary Scientific Institution “Medical Genetic Research Center named after A.I. Academician N.P. Bochkov"; Chief Freelance Specialist in Medical Genetics of the Ministry of Health of Russia
Alexey Lundup, Director of the Scientific and Educational Resource Center for Cellular Technologies, Peoples' Friendship University of Russia